Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19? diabetes metab syndr • June 1, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. diabetes metab syndr • April 28, 2020
Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. diabetes metab syndr • April 28, 2020
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. diabetes metab syndr • April 26, 2020
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. diabetes metab syndr • April 7, 2020
Improving inpatient glycemic control by diabetes education program in internal medicine residents. diabetes metab syndr • August 14, 2019
The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. diabetes metab syndr • January 16, 2019